Company News

Silab Studies Examine Active Ingredient

Innovation accelerates the reconstruction of skin.

Scarring is a natural biological phenomenon for repairing damage to the skin or to deeper tissues such as muscles and bones. This process includes a cascading reaction of biochemical events that are highly regulated in space and time. Their sole aim is to replace the lost or devitalized cell and tissue structures.

Recently, a brand-new research strategy has emerged to support this tissue regeneration. It consists in applying biocompatible and biodegradable materials on lesions, promoting cellular migration and neocolonization and the high mobilization of growth factors, which are biological substances essential to this process.

This innovative approach has been one of the main work focuses of the Silab advanced research laboratories for several years.
To manage this ambitious research program and see it through to completion, the company has two necessary and complementary internal assets which are know-how in the production of natural biopolymer matrices and extensive expertise in cutaneous biology.

The first phase of this project was formalized in 2007, with the marketing of Glyco-Repair. This biomolecule, a genuine network of natural oligo-galactomannans, stimulates the migratory potential of the skin cells (Figure 1) and the endogenous production of key growth factors in the skin repair process.

Studies undertakenin vivo have confirmed that this active ingredient accelerates the reconstruction of damaged skin and helps restore its essential functions.

The next phase of this project will be implemented soon with the marketing of a new technology which will provide an innovative approach to cutaneous regeneration by significantly improving the reorganization of matrices. Like all Silab innovations, this technology currently has a patent pending.

Keep Up With Our Content. Subscribe To Happi Newsletters